Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지

The effect of periodontal therapy on the gingival thickness in patients with drug-induced gingival enlargement

치주치료가 약물성 치은비대 환자의 치은두께에 미치는 효과에 관한 연구

  • Kim, Won-Kyung (Department of Dentistry, College of Medicine, University of Ulsan.) ;
  • Baek, Jin (Department of Dentistry, Asan Medical Center) ;
  • Lee, Young-Kyoo (Department of Dentistry, College of Medicine, University of Ulsan.)
  • 김원경 (울산대학교 의과대학 치과학교실) ;
  • 백진 (서울아산병원 치과) ;
  • 이영규 (울산대학교 의과대학 치과학교실)
  • Published : 2005.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to observe the effects of periodontal therapy, including nonsurgical periodontal therapy with azithromycin, surgical therapy, and maintenace therapy on the drug-induced gingival enlargement, by means of measuring gingival thickness. The test group of 18 patients with drug-induced gingival enlargement received scaling, root planing with azithromycin for 5 days, with or without surgical periodontal treatment. The control group of 18 patients who had not taken any medication, received scaling and root planing, with or without surgical periodontal treatment. Both groups received supportive periodontal therapy every 3 months for 2 years. The mean period of total treatment is 32 months in the test group and 31 months in the control group. The thickness of the buccal gingiva was measured using an ultrasonic device of $SDM^{(R)}$(Krupp Corp., Essen, Germany). The results revealed that the test $group(1.21{\pm}0.51mm)$ showed statistically thicker buccal gingiva than the control $group(1.01{\pm}0.3mm)$. In the test group, the buccal gingiva was thickest on 2nd molars and was thinnest on canines of both dental arches. In the control group, the buccal gingiva was thickest on central incisors in the maxilla and 2nd molars in the mandible, while the thinnest areas were on canines in the maxilla and 1st premolars in the mandible. It would be concluded that the periodontal treatment with azithromycin aids in decreasing the degree of the gingival enlargement but cannot prevent the recurrence completely.

Keywords

References

  1. Camargo PM. Melnick PR. Pirih FQ. Lagos R & Takei HH. Treatment of drug-induced gingival enlargement: Aesthetic and functional considerations. Periodontology 2000 2001; 27: 131-138 https://doi.org/10.1034/j.1600-0757.2001.027001131.x
  2. Academy Report. Drug-Associated gingival enlargement. J Periodontol 2004; 75 : 1424-1431 https://doi.org/10.1902/jop.2004.75.10.1424
  3. Jones JE. Weddell JA McKnown CG. Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population. J Oral Maxillofac Surg 1988; 46: 385-390 https://doi.org/10.1016/0278-2391(88)90222-4
  4. Boltchi FE. Rees TD. Iacopino AM. Cyclosporine A-induced gingival overgrowth: A comprehensive review. Quintessence Int 1999;30:775-783
  5. Barclay S. Thomason JM. Idle JR. Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992; 19:311-314 https://doi.org/10.1111/j.1600-051X.1992.tb00650.x
  6. Fattor L. Stablein M. Bredfeldt G et al. Gingival hyperplasia: A side effect of nifedipine and diltiazem. Spec Care Dent 1991: 11: 107-109 https://doi.org/10.1111/j.1754-4505.1991.tb00828.x
  7. Kimball OP. The treatment of epilepsy with sodium diphenyl hydantoinate. JAMA 1939:112:1244-1245 https://doi.org/10.1001/jama.1939.02800130028009
  8. Nishikawa S, Nagata T, Morisaki I, et al. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. J Periodontol 1996: 67: 463-471 https://doi.org/10.1902/jop.1996.67.5.463
  9. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996: 23: 165-175 https://doi.org/10.1111/j.1600-051X.1996.tb02072.x
  10. Hallmon WW, Rossmann JA, The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontology 2000 1999: 21: 176-196 https://doi.org/10.1111/j.1600-0757.1999.tb00175.x
  11. McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivla scores, and cyclosporin. Oral Surg Oral Med Oral Pathol. 1987:64:293-297 https://doi.org/10.1016/0030-4220(87)90007-7
  12. Kantarci A, Cebeci I, Tuncer O, et al. Clinical effects of periodontal therapy on the severity of cyclosporin A-inducedbgingival hyperplasia. J Periodontol 1999: 70:587-593 https://doi.org/10.1902/jop.1999.70.6.587
  13. Hancock RH, Swan RH. Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque. J Clin Periodontol 1992:19:12-14 https://doi.org/10.1111/j.1600-051X.1992.tb01141.x
  14. Darbar UR, Hopper C, Speight PM, Neman HN. Combined treatment approach to gingival overgrowth due to drug therapy. J Clin Periodontol 1996: 23: 941-944 https://doi.org/10.1111/j.1600-051X.1996.tb00515.x
  15. Pilloni A, Camargo PM, Carere M, Carraza Jr. FA. Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: Gingivectomy versus periodontal flap. J Periodontol 1998: 69:791-797 https://doi.org/10.1902/jop.1998.69.7.791
  16. Seymour RA , Smith DG. The effect of a plaque control program on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991: 18; 107-110 https://doi.org/10.1111/j.1600-051X.1991.tb01698.x
  17. Hall WE. Dilantin hyperplasia: a preventable lesion. J Periodontal Res 1969; 4:36-37 https://doi.org/10.1111/j.1600-0765.1969.tb01943.x
  18. Kydd WL, Daly CH, Wheeler JB III. The thickness measurement of masticatory mucosa in vivio. International Dental Journal 1971:21:430-441
  19. Goaslind GD, Robertson PB, Mahan CJ, Morrison WW, Olson JV. Thickness of facial gingiva. J Periodontol 1977:48: 768-771 https://doi.org/10.1902/jop.1977.48.12.768
  20. Eger T, Muller HP, Heinecke A. Ultrasonic determination of gingival thickness. Subject variation and influence of tooth type and clinical features. J clin peirodontol 1996; 23: 839-845 https://doi.org/10.1111/j.1600-051X.1996.tb00621.x
  21. Müller HP, Schaller N, Heinecke A. Thickness of masticatorz mucosa. J Clin Periodontol 2000:27:431-436 https://doi.org/10.1034/j.1600-051x.2000.027006431.x
  22. 강철흔, 장문택, 류성훈, 김형섭 : '한국 성인의 각화치은 두께측정에 관한 연구', 대한치주과학회지, 제30권(1호): 179-185, 2000
  23. Vandana KL, Savitha B. Thickness of gingiva in association with age, gender and dental arch location. J Clin Periodontol 2005; 32: 828-830 https://doi.org/10.1111/j.1600-051X.2005.00757.x
  24. 김성준, 김태일, 설양조 등. 치은두께와 임상검사 지수들과의 상관관계. 대한치주과학회지 2005: 35:537-548
  25. Ellis JS, Seymour RA, Steele JG, et al. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol 1999: 70: 63-67 https://doi.org/10.1902/jop.1999.70.1.63
  26. Somacarrera ML, Lucas M. Schully C, Barrios C. Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients. Br Dent J 1997: 183:89-94 https://doi.org/10.1038/sj.bdj.4809430
  27. Ilgenli T, Atilla G, Baylas H. Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol 1999:70:967-972 https://doi.org/10.1902/jop.1999.70.9.967
  28. Ikawa K. Ikawa M. Shimauchi H. et al. Treatment of gingival overgrowth induced by Manidipine Adiministration. A Case Report J Periodontol 2002: 73: 115-122 https://doi.org/10.1902/jop.2002.73.1.115
  29. 조형호, 이영규. 장기이식환자에서의 치은비대에 관한 Azithromycin의 효과. 대한치주과학회지 1998: 28: 829-836 https://doi.org/10.5051/jkape.1998.28.4.829
  30. Gomez E, Sanchez-Nunez M. Sanchez JE, et al. Treatment of cyclosporininduced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 1997: 12: 2694-2697. https://doi.org/10.1093/ndt/12.12.2694
  31. Nash MM, Zaltzman JS. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 1998:65:1611-1615 https://doi.org/10.1097/00007890-199806270-00012